Autoimmune haemolytic anaemia associated with ciprofloxacin.

Summary Ciprofloxacin has become the treatment of choice for salmonella infections due to its clinical efficacy and the development of resistance to other antibiotics. It shortens the course of clinical disease and the period of excretion in enteric salmonella infections, has excellent in-vitro activity against all the bacterial pathogens that commonly cause infective diarrhoea (Wilcox & Spencer 1992) and side effects are uncommon. We report here the first case of autoimmune haemolytic anaemia (AIHA) associated with its use.

[1]  R. Spencer,et al.  Quinolones and Salmonella gastroenteritis. , 1992, Journal of Antimicrobial Chemotherapy.

[2]  A. Salama,et al.  Autoantibodies and drug‐or metabolite‐dependent antibodies in patients with diclofenac‐induced immune haemolysis , 1991, British journal of haematology.

[3]  R. Smego,et al.  Quinolone antibiotics in the treatment of Salmonella infections. , 1990, Reviews of infectious diseases.

[4]  H. Heuft,et al.  [Fatal course of immune hemolytic anemia following administration of diclofenac]. , 1990, Beitrage zur Infusionstherapie = Contributions to infusion therapy.

[5]  C. Levene,et al.  Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy. , 2009, Scandinavian journal of haematology.

[6]  S. Mitsutani.  [Appearance of monoclonal gammopathy and auto-immune hemolytic anemia following intake of drugs]. , 1985, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

[7]  G. Landini,et al.  Fatal acute immune haemolytic anaemia caused by nalidixic acid. , 1982, British medical journal.

[8]  D. R. Jones,et al.  Haemolytic anaemia with nalidixic acid. , 1972, British medical journal.